Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- BUSINESS NEWS IN BRIEF
June 16, 2008
- Banyu to Develop More Vaccines in Japan: New President Timney
June 16, 2008
- 3 Major Generics Makers Aim at Conservative Sales Targets for OTC Version of Amlodipine
June 16, 2008
- 34 Companies to Enter Market for Amlodipine with 70 Generic Products
June 16, 2008
- Approval Recommended for OTC Version of Miconazole for Vaginal Candidiasis
June 9, 2008
- BUSINESS NEWS IN BRIEF
June 9, 2008
- Departure of Global Companies from Japan Is Serious Problem: Mr Yagi
June 9, 2008
- Top 4 Generic Makers' Combined Sales Up 9.4% to \138.9 Bil.
June 9, 2008
- DVx's Excimer Laser Lead Withdrawal System Recommended for Approval
June 9, 2008
- Sawai: Sales Up 9.7% with Double-digit Fall in Profits
June 9, 2008
- Guidelines on HRT to Be Completed in November
June 9, 2008
- Towa Pharm.: Sales, Profits Fall Short of Mid-Term Plan
June 9, 2008
- Sutent Drug of Choice for Progressive RCC
June 9, 2008
- GENERICS NEWS IN BRIEF
June 9, 2008
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
June 9, 2008
- Pharma Industry Must Be Trusted by the Public: Dr Takenaka
June 9, 2008
- Mr Shoda to Lead JPMA to Create Innovation-Friendly NHI Pricing System
June 9, 2008
- Combined Sales Exceed \6 Tril. Mark for 23 TSE 1st Section Companies
June 9, 2008
- TOPICS：Mr Kise of ATOL Elected President of Wholesalers' Fair Trade Council
June 9, 2008
- BUSINESS RESULTS
June 9, 2008
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…